Type 1 diabetes mellitus (T1DM), also known as autoimmune diabetes, is a chronic disease
characterized by insulin deficiency due to pancreatic β-cell loss and leads to …

Type 1 diabetes (T1D) results from the progressive destruction of pancreatic β-cells in a
process mediated primarily by T lymphocytes. The T1D research community has made …

Over the past 15 years, SCT has emerged as a promising treatment option for patients with
severe autoimmune diseases (ADs). Mechanistic studies recently provided the proof-of …

Recent interest in testing whether the success of antigen-specific immunotherapy (ASIT) for
autoimmune diseases in mice can be translated to humans has highlighted the need for …

Latent autoimmune diabetes in adults (LADA) is the most common form of autoimmune
diabetes diagnosed in adults. Similar to type 1 diabetes, the prevalence of LADA is impacted …

Cytometric immunophenotyping is a powerful tool to discover and implement T‐cell
biomarkers of type 1 diabetes (T1D) progression and response to clinical therapy. Although …

OBJECTIVE The characterization of diverse subtypes of diabetes is a dynamic field of
clinical research and an active area of discussion. The objective of this study was to identify …

Identifying T cell epitopes of islet autoantigens is important for understanding type 1
diabetes (T1D) immunopathogenesis and to design immune monitoring and intervention …

Recent advances in understanding the etiology of obesity, metabolic syndrome, and type 2
diabetes (T2D) have established involvement of the immune system. These developments …

As screening studies and preventive interventions for type 1 diabetes (T1D) advance rapidly,
the utility of islet autoantibodies (IAbs) in T1D prediction comes with challenges for early and …